The Ethics of Elective Growth Hormone Therapy in Children with Idiopathic Short Stature

J Clin Ethics. 2021 Fall;32(3):206-214.ABSTRACTIn this article, we analyze the ethics of elective growth hormone (GH) therapy in children with idiopathic short stature (ISS). We discuss recent clinical research regarding the efficacy, side-effects, and risks of GH therapy, and argue that GH therapy is ethically unjustifiable for most children with ISS.PMID:34548429
Source: Journal of Clinical Ethics - Category: Medical Ethics Authors: Source Type: research